RIPK2 (Phospho-Ser176) Polyclonal Antibody

Rabbit Anti-RIPK2 (Phospho-Ser176) Polyclonal Antibody

Product Specifications

Background

RIPK2 (Receptor Interacting Serine/Threonine Kinase 2) is a Protein Coding gene. Diseases associated with RIPK2 includeLymphoproliferative Syndrome, X-Linked, 2andHuman Granulocytic Anaplasmosis. Among its related pathways areOvarian tumor domain proteasesandActivated TLR4 signalling.

CAS Number

9007-83-4

Product Name Alternative

Receptor-interacting serine/threonine-protein kinase 2; CARD-containing interleukin-1 beta-converting enzyme-associated kinase; CARD-containing IL-1 beta ICE-kinase; RIP-like-interacting CLARP kinase; Receptor-interacting protein 2; RIP-2; Tyrosine-protein kinase RIPK2

Gene ID

8767

Accession Number

O43353

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from part region of human RIPK2 (Phospho-Ser176) Antibody protein

Clonality

Polyclonal

Tag

RIPK2

Applications

WB, ELISA, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

61kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

This antibody detects endogenous levels of RIPK2 when Phospho occurs at Ser176

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300; ELISA 1:2000-20000